Structural studies have shown that estrogens increase dendritic spine number in the dorsal CA1 field of rat hippocampus using Golgi impregnation as well as the number of dorsal CA1 synapses visualized via electron microscopy. The present study was carried out to further these findings by examining changes in the levels of pre-and postsynaptic proteins using radioimmunocytochemistry (RICC). In this study, 2 days of estradiol-benzoate treatment produced significant and comparable increases in synaptophysin, syntaxin, and spinophilin immunoreactivity (IR) in the CA1 region of the dorsal hippocampus of ovariectomized female rats. For spinophilin, IR was also increased in the hilar region of the dentate gyrus as well as CA3. In all cases, the nonsteroidal estrogen antagonist CI628, which has been previously shown to block spine formation, inhibited the effects of estrogen. However, these protein differences were not detected in whole hippocampus using Western blots. These findings add to a growing body of evidence that estrogens increase synapses in the CA1 region of hippocampus along with changes in previously unidentified sites. These results also suggest that RICC is a rapid and sensitive method for examining molecular changes in synaptic profiles in anatomically distinct brain regions. (Endocrinology 142: 1284 -1289, 2001) A GROWING BODY of evidence implicates ovarian steroids in synaptic plasticity of the hippocampus. Estrogens have been shown to modulate CA1 dendritic spine and synapse numbers during the estrous cycle; their numbers being highest during proestrous, when ovulation takes place and sexual behaviors are observed (1-4). Moreover, estrogen replacement in ovariectomized (OVX) female rats increases spine number as well as excitatory synapses on apical and basal dendrites of CA1 pyramidal neurons (4 -6). This effect can be significantly attenuated with the selective estrogen receptor modulator (SERM), CI628 (6).
creased in the hilar region of the dentate gyrus as well as CA3. In all cases, the nonsteroidal estrogen antagonist CI628, which has been previously shown to block spine formation, inhibited the effects of estrogen. However, these protein differences were not detected in whole hippocampus using Western blots. These findings add to a growing body of evidence that estrogens increase synapses in the CA1 region of hippocampus along with changes in previously unidentified sites. These results also suggest that RICC is a rapid and sensitive method for examining molecular changes in synaptic profiles in anatomically distinct brain regions. (Endocrinology 142: 1284 -1289, 2001) A GROWING BODY of evidence implicates ovarian steroids in synaptic plasticity of the hippocampus. Estrogens have been shown to modulate CA1 dendritic spine and synapse numbers during the estrous cycle; their numbers being highest during proestrous, when ovulation takes place and sexual behaviors are observed (1) (2) (3) (4) . Moreover, estrogen replacement in ovariectomized (OVX) female rats increases spine number as well as excitatory synapses on apical and basal dendrites of CA1 pyramidal neurons (4 -6) . This effect can be significantly attenuated with the selective estrogen receptor modulator (SERM), CI628 (6) .
CI628 is a nonsteroidal SERM that blocks estrogen receptor (ER) transcriptional activation of ER␣ and ER␤ via the classical estrogen response element pathway (7, 8) . Although SERMs can have both agonist and antagonist properties, it has been shown that CI628 predominantly acts as an antiestrogen by blocking estrogen-induced progesterone receptor induction (9, 10) PRL release (11) and lordosis behavior (9) . Thus, it should not be surprising that CI628 blocks estrogeninduced formation of hippocampal dendritic spines as measured by Golgi staining (6) .
Despite progress in characterizing estrogen regulation of hippocampal synaptogenesis, the mechanism and function of such estrogen action has not been fully elucidated. This may be due, in part, to difficulties with the techniques involved. Studies have traditionally employed Golgi impregnation, electron microscopy, and confocal microscopy to examine estrogen's effects on synaptic plasticity, restricting such studies to labs where these anatomical techniques are available. Determining the level of proteins associated with synapses may be another means to examine changes in synaptogenesis as well as identify molecular changes associated with this process. However, techniques such as Western blotting are unable to examine protein levels within discrete hippocampal laminae and traditional immunocytochemistry techniques measuring light density of DAB (3,3Ј-diaminobenzidine) staining or immunofluorescence are unreliable for determining relative protein levels.
The purpose of the present study was to examine in OVX rats the effects of estrogen, and the estrogen antagonist, CI628, on proteins associated with pre-and postsynaptic structures using a rapid and sensitive method of examining site-specific changes in relative protein levels, viz. radioimmunocytochemistry (RICC). This was carried out by using immunocytochemistry with primary antibodies directed against pre-and postsynaptic proteins followed by a radiolabeled secondary antibody for detection. Western immunoblotting was also employed to determine whether such protein changes could be detected in whole hippocampal tissue. Antibodies directed against synaptophysin, syntaxin, and spinophilin were employed in this study. Synaptophysin is a vesicular protein whereas syntaxin is a presynaptic membrane-bound protein; both proteins are implicated in vesicular docking and are considered to be reliable markers of synaptogenesis (12) (13) (14) . Spinophilin is a recently character-ized protein found predominantly in dendritic spines and implicated in spine homeostasis (15, 16) .
Materials and Methods

Surgery and estrogen treatment
All procedures were carried out in accordance with the guidelines established by the NIH Guide for the Care and Use of Laboratory Animals. Adult female Sprague Dawley rats (Charles River Laboratories, Inc. Lexington, MA) weighing 180 -200 g were ovariectomized under Metofane anesthesia and allowed 1 week to recover. Rats in this experiment were injected for four consecutive days. During the first 3 days, rats were injected with either CI628 (nitromiphene citrate [␣-(4-pyrrolidinethoxyl)phenyl-4-methoxy-␣-nitrostilbene]; 10 mg/kg sc; Parke-Davis, Ann Arbor, MI) or sterile distilled H 2 O vehicle (H 2 O). On the third and fourth days, rats were injected with either estradiol benzoate (EB; 10 g/kg sc; Sigma, St. Louis, MO) or sesame oil vehicle (Oil). That is, all animals received three days of CI638 or H 2 O and two days of either EB or oil (n ϭ 6 -8/group).
For RICC, animals were deeply anesthetized 24 h following the final treatment, and transcardially perfused with 0.9% saline followed by freshly prepared 4% paraformaldehyde in 0.1 m PBS, pH 7.4, containing 0.03% glutaraldehyde. The brains were then postfixed in the perfusate overnight and sliced at 40 m thickness along the coronal plane using a microtome. Sections were then stored in cryoprotectant (30% glycerol and 30% ethylene glycol in 0.1 m PB) at Ϫ20 C.
For Western immunoblotting, OVX animals (n ϭ 5/group) were decapitated 24 h following 2 days of treatment with either EB or oil as described above. Animals treated with CI628 were not included in the immunoblot experiment. The brains were removed and the hippocampus was rapidly dissected out on a saline-rinsed chuck sitting in wet ice and then snap frozen in dry ice and stored at Ϫ80 C until used.
RICC
All antibodies employed in this study were previously titrated to determine concentrations exhibiting maximum signal to minimum background binding. Free-floating sections were serially washed (5 ϫ 5 min) in 0.05 m phosphate buffer (PB), pH 7.4, to remove cryoprotectant. Sections were then mounted onto Vectabond-coated slides (Vector Laboratories, Inc. Burlingame, CA) and allowed to dry for 1 h. Tissue was then washed (3 ϫ 5 min) in 0.1 m PBS, pH 7.4, at room temperature (RT) and then submitted to treatment depending on the antibody examined. For immunoreactivity (IR) to synaptophysin and syntaxin, tissue was blocked with 2% normal goat serum in PBS containing 0.1% Triton ϫ100 for 1 h at RT. Tissue was then incubated overnight at 4 C in primary antibody (1:1000) diluted in PBS (monoclonal anti-synaptophysin raised in mouse, monoclonal antisyntaxin raised in mouse, both are IgG1 isotype; Sigma). Sections incubated without primary antibody were also included as negative controls. All sections were then washed in PBS and incubated with secondary antibody (antimouse Ig whole antibody raised in sheep with [ 35 S] label, specific activity ϭ 900 Ci/mmol, Amersham Pharmacia Biotech, Piscataway, NJ) in PBS (1:100) for 1 h at RT.
For spinophilin IR, sections were blocked in 2% normal horse serum containing 0.1% Triton X-100 for 1 h at RT. Sections were then incubated overnight in primary antibody (polyclonal anti-spinophilin raised in rabbit; 1:2000; see 1 for antibody purification methods) in PBS overnight at 4 C. Sections were then washed in PBS and incubated with secondary antibody (antirabbit Ig whole antibody raised in donkey with [ 35 S] label, specific activity ϭ 1466 Ci/mmol, Amersham Pharmacia Biotech) in PBS (1:100) for 1 h at RT. Following washes (3 ϫ 15 min) in ice-cold PBS and a distilled H 2 O rinse, all sections included in this study were left to air-dry overnight. All slides were incubated collectively in the same dish at each step except the no primary controls which were kept separate from other slides throughout the experiment. Slides were then apposed to 3 H-Hyperfilm (Amersham Pharmacia Biotech) alongside microscalecalibrated [
14 C] standard strips (Amersham Pharmacia Biotech), which were included with every film cassette. Multiple exposure times were carried out to determine the optimal density for each primary antibody (viz. 2-3 days).
Western blots
Membranes were extracted from hippocampal samples by homogenizing tissue in ice-cold buffer containing 0.32 m sucrose, 2 mm EDTA, 2 mm EGTA, and 20 mm HEPES along with protease inhibitors (trypsin inhibitor, 1 mg/ml; aprotinin, 7 mg/ml; pepstatin, 4 mg/ml). Protein tissue was centrifuged at 4 C (500 ϫ g for 10 min) and the supernatant was again centrifuged at 4 C (32,000 ϫ g for 30 min). The pellet was resuspended in 100 mm PBS (pH, 7.4) and centrifuged at 4 C (31,000 ϫ g for 30 min) and the resultant pellet was resuspended in 100 mm PBS and stored at Ϫ80 C.
After estimation of protein concentration with a Bio-Rad Laboratories, Inc. (Hercules, CA) protein assay, aliquots containing 2 g of protein from each animal were separated by NuPAGE 4 -20% Bis-Tris gel (NEN Life Science Products) and transferred onto a PVDF membrane (Amersham Pharmacia Biotech). The membranes were then blocked with TBS-T (25 mm Tris-base, pH 7.4, 137 mm NaCl, and 0.1% Tween 20) containing 5% nonfat milk for 1 h at room temperature. Membranes were washed in TBS-T and probed with 1:5000 antisynaptophysin, 1:5000 antisyntaxin, and 1:10,000 antispinophilin antibodies overnight at 4 C. Membranes were again washed in TBS-T and then incubated with either antimouse or antirabbit (depending on how primary Ab was raised) IgG HRP-labeled secondary Ab (1:10,000) for 2 h. All antibodies used for Western blots were titrated to determine maximum signal to minimum background binding to determine at the concentrations listed here. The antibody-reactive bands were visualized using chemiluminescence (ECL Western detection kit; Amersham Pharmacia Biotech).
Data format and analysis
For analysis of RICC, optical density measures were blindly taken from every twelfth section of dorsal hippocampus (between Ϫ2.5 and Ϫ6.1 mm from bregma) of each rat using computerized image-analysis software (MCID-M4, Imaging Research, Inc., St. Catherines, Ontario, Canada). Density of the corpus callosum (which should contain no preor postsynaptic protein) was measured as background and subtracted from the density of each hippocampal subregion. It was considered important for binding densities to be consistent between different films. Consequently, the convention of expressing optical densities relative to standard strips (reported as fmol/mg) as is used in quantitative receptor autoradiography was chosen instead of expressing the data as relative optical densities, which can vary greatly from film to film and also vary with subtle differences in exposure time. Thus, binding densities were converted to fmol/mg of tissue based on the [ 14 C] standard calibration and the specific activity of the radiolabeled secondary antibody. Yet, an important caveat should be noted. Considering the limitations of antibody penetration into tissue, these values are intended to indicate relative changes in IR rather than absolute protein levels. For each primary antibody, mean IR was analyzed using a mixed factorial ANOVA with treatment as a between measure and hippocampal region as a within measure. Post hoc examination was carried out using Scheffé's F test.
For analysis of immunoblots, relative optical density was measured from the band migrating at the appropriate weight for each antibody, although each antibody produced only one major band. Optical densities were obtained from 5 lanes per group (each lane contained tissue from a single rat). Thus, analysis (one-way ANOVA) was carried out on n ϭ 5 rats/group for each antibody.
Results
Antibody specificity
Before carrying out RICC, all primary antibodies used here were first tested using immunocytochemistry. The RICC binding distributions and antibody concentrations exhibiting maximum signal to background were the same between the two techniques. Thus, RICC produces the same binding distributions as seen using the more traditional method. Also, the distribution of these antibodies in hippocampus is the same as shown by others using immunocytochemistry (15) . For all antibodies, binding was most dense in cortex and hippocampus with little binding in the corpus callosum. In the hippocampus, binding was most dense in the dendritic fields with lightest binding within the principal cell layers (Fig. 1) .
To determine specific binding of secondary [ 35 S]-labeled antibody, some sections were incubated without primary antibody. Figure 1 shows that the antirabbit secondary antibody displayed no specific binding when compared with sections incubated with primary antibody. Similar results were seen with the antimouse secondary antibody. The synaptophysin and syntaxin monoclonal antibodies used here are commercially available. To determine their specificity, these antibodies were tested using Western blots on hippocampal tissue. The synaptophysin and syntaxin antibodies recognized one major band each migrating at 38 kDa and 35 kDa, respectively (data not shown), which are the molecular weights of synaptophysin and syntaxin, indicating specificity for their respective proteins. The spinophilin antibody employed in this study has been tested for specificity elsewhere (15) . To further test antibody specificity, Western blots were carried out on hippocampal tissue here (see Fig. 4 ) as well as by others using spinophilin knockout mice. The same spinophilin antibody used here produced no major bands in tissue from these knockout mice (16) .
Effects of estrogen on synaptic protein IR
The mean IR of synaptophysin, syntaxin, and spinophilin for each hippocampal region are presented in Fig. 2 . There was a significant interaction between hippocampal region and treatment group for synaptophysin (F (12,96) ϭ 5.340, P Ͻ 0.0001). Post hoc analysis revealed higher synaptophysin IR in animals treated with EB only (H 2 OϩEB group) when compared with other groups (P Ͻ 0.05) in both CA1 stratum radiatum and stratum oriens. No other synaptophysin IR differences were observed. Similarly, differences in syntaxin IR were observed only in CA1 stratum radiatum (F (3, 22) ϭ 3.105, P ϭ 0.0493) and stratum oriens (F (3, 22) ϭ 4.085, P ϭ 0.0190). Syntaxin IR was highest in these two CA1 subregions in the H 2 OϩEB rats when compared with CI628ϩEB (P Ͻ 0.05) and H 2 OϩOil (P Ͻ 0.05) but not CI628ϩOil-treated rats.
Analysis of spinophilin IR (Figs. 2 and 3 ) revealed a significant interaction between treatment group and hippocampal region (F (12, 96) ϭ 3.762; P Ͻ 0.0001). In the case of spinophilin, however, greater spinophilin IR was observed in the estrogen-treated group (EBϩH 2 O) in comparison to all three other groups in CA1 and the hilar region of the dentate gyrus (P Ͻ 0.05). Rats that received EBϩH 2 O treatment also showed greater spinophilin IR in CA3 in comparison to those treated with CI628ϩEB (P Ͻ 0.05).
Conversely, no significant protein IR differences were observed from Western blots of membrane tissue from whole hippocampus (Fig. 4) .
Discussion
The RICC technique, as employed here, is not intended to quantify actual synapse number and cannot replace anatomical studies such as Golgi impregnation and electron microscopy that measure structural changes in spine and synapse numbers. Yet, this technique may be used as an indictor of synaptic reorganization by examining relative changes in specific synaptic proteins within discrete regions in instances where Western blotting is unable to detect such changes. Depending upon the protein examined, RICC may also be helpful in determining dendritic spine changes associated with ongoing synaptic activity and provide insight about molecular changes associated with such activity. This technique has been used since the early 1990s (17) and has been successfully employed in the hippocampus of rats (18 -20) and humans (21) . In many instances (18, 19, 21) , changes in protein IR measured by this technique reflected changes in messenger RNA levels measured by in situ hybridization. Estrogen is shown to increase the synaptic proteins examined here by approximately 20 -30% in the CA1 region of hippocampus (Fig. 2) . This effect is in accordance with previous studies demonstrating such an increase in CA1 spine number (5, 6) and excitatory synapses (3) in response to estrogen. Further, these are the first findings to demonstrate estrogen-induced changes in synaptic markers in the hilus of the dentate gyrus and CA3 suggesting that target sites for estrogen's action in the hippocampus is more widespread than originally thought. Moreover, the nonsteroidal estrogen antagonist, CI628, prevented these effects. This too complies with previous anatomical findings, which demonstrate that Ͻ yellow Ͻ orange) . B, Schematic diagram identifying specific hippocampal regions from where measures were taken. cc, corpus callosum; DG, dentate gyrus; (so), stratum oriens; (sr), stratum radiatum; (slu); stratum lucidum; (mo), molecular layer.
CI628 at the dose used here inhibits estrogen-induced dendritic spine induction on CA1 pyramidal neurons (6). It is not surprising that Western blots on whole hippocampal tissue did not reveal any group differences in these proteins. Such findings underscore the importance of using a technique which allows for the evaluation of protein changes in discrete regions while maintaining anatomical integrity.
That presynaptic proteins examined here (viz. synaptophysin and syntaxin) were affected by estrogen treatment suggests that afferents to CA1 pyramidal neurons may either be indirectly compensating for estrogen-induced changes in CA1 pyramidal cells, interneurons, or astrocytes or they are directly responding to estrogen treatment themselves. Indeed, ascending basal forebrain cholinergic neurons and locus coeruleus norepinephrine neurons both innervate this site and both express nuclear ERs (22) (23) (24) (25) (26) . In addition, Shaffer collaterals arising from CA3 neurons innervate CA1 pyramidal cells. Although neither CA1 nor CA3 cells have been shown to exhibit nuclear ER␣ either by immunocytochemistry (27) , or by autoradiography (28), these cells have been reported to exhibit some (albeit little) binding of 125 I-estrogen (29) and express messenger RNA for both ER␣ and ER␤ (30) .
Murphy and colleagues (31) originally posited that the actions of estrogen on CA1 hippocampal plasticity may be mediated through inhibitory interneurons. There is suggestive evidence that GABA (␥-aminobutyric acid) interneurons contain nuclear ER␣ (27) and it has been shown in vitro that estrogens inhibit GABA and glutamic acid decarboxylase (the rate-limiting enzyme in GABA synthesis) IR in these estrogen-sensitive cells (31) . This may confer a period of disinhibition of excitatory synapses and may increase NMDA (N-methyl-d-aspartate) receptor expression on pyramidal neurons. This finding is relevant because it is thought that estrogen-induced synaptogenesis is mediated via NMDA receptors. NMDA receptors are up regulated on CA1 pyramidal neurons by estrogen treatment (27, 32, 33) and NMDA receptor blockade prevents estrogen-induced CA1 synaptogenesis (34) .
It has been postulated that the rapid effects of estrogens may occur outside the nucleus via membrane-associated ERs, which are thought capable of initiating signal transduction (35) (36) (37) . A recent ultrastructural analysis of ER␣ IR has determined that, in addition to location in the nuclei in some nonprinciple cells, extranuclear ER␣ is present in the axons and axon terminals as well as dendritic spines of the hippocampus (38) . The majority of ER␣-labeled terminals are seen in the dentate gyrus and CA1 region of the hippocampus. These authors also observed extranuclear ER␣ IR in processes prominent near dendritic spines that are presumed to be from astrocytes. These findings allow the possibility that estrogen may act locally upon ERs at the excitatory synapses in CA1.
The fact that CI628 blocked estrogen up-regulation of synaptic and spine protein IR just as it had blocked estrogen induction of spines (6), is consistent with the action of estrogens via a nuclear ER. However, membrane-associated ER may also be involved, because the ability of such nonnuclear ER to stimulate second messenger systems (37) is blocked by a number of estrogen antagonists, including tamoxifen (Levin, E. R., personal communication; May, 24, 2000) , which is similar in its mode of action to CI628. Thus, until the actions of extranuclear ERs at the CA1 synaptic site are determined, target sites for estrogen's actions could possibly be, either uniquely or collectively, any of the CA1 inputs, astrocytes, inhibitory interneurons, and/or the CA1 dendritic spines themselves.
That estrogen increases spinophilin IR in CA1, where dendritic spine induction has been demonstrated by structural studies (4 -6) supports the use of spinophilin as a marker for examining changes in spine number. However, estrogen was shown here to also increase spinophilin in the hilar region of the dentate gyrus. How might these observations be reconciled? One possibility is that these data may be revealing previously unidentified sites of estrogen modulation of spine structure. An alternative possibility is that spinophilin levels are representative of synaptic activity. Because spinophilin acts functionally as a cytoskeletal scaffolding protein (it serves to bundle F-actin filaments in vitro; 39), it is potentially involved in regulating the dense F-actin-based cytoskeleton found in dendritic spines. In addition, spinophilin serves as an anchor for protein phosphatase-1 (15) , an enzyme that participates not only in regulation of the F-actin-based cytoskeleton (40) , but also in the regulation of the activity of several ion channels and neurotransmitter receptors found in dendritic spines (41) . Thus, spinophilin levels may be dictated not only by spine density per se, but also by the level of ongoing and previous synaptic activity. It is becoming increasingly apparent that spine morphology and biochemical content are responsive to altered synaptic activity (42) , and it will be of interest to further examine the role of estrogen in this context. Thus, our data are consistent with the idea that estrogen may be inducing changes in spines located in hippocampal regions outside CA1 such as the dentate gyrus. Interestingly, ER␣ has been detected surrounding the spine apparatus in select spines in both CA1 and the dentate gyrus (38) and, in these regions at least, it may be colocalized with spinophilin.
In summary, these data identify the involvement of three synaptic proteins in the estrogen-mediated regulation of synaptic plasticity in the hippocampus. They also uncover previously unidentified sites (viz. hilar region of the dentate gyrus and CA3) for estrogen actions in the dorsal hippocampus. Furthermore, these findings demonstrate that RICC is a relatively rapid and sensitive technique for examining synaptic changes in distinct brain regions without compromising anatomical integrity.
